Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Non Operating Income (2016 - 2025)

Prestige Consumer Healthcare has reported Non Operating Income over the past 16 years, most recently at -$10.0 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 2734.28% year-over-year to -$10.0 million; the TTM value through Dec 2025 reached -$24.0 million, up 74.27%, while the annual FY2025 figure was -$5.0 million, 92.54% up from the prior year.
  • Non Operating Income for Q4 2025 was -$10.0 million at Prestige Consumer Healthcare, up from -$10.5 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $49.9 million in Q1 2022 and troughed at -$68.7 million in Q1 2023.
  • A 5-year average of -$12.7 million and a median of -$11.6 million in 2024 define the central range for Non Operating Income.
  • On a YoY basis, Non Operating Income climbed as much as 263.42% in 2022 and fell as far as 15449.52% in 2022.
  • Year by year, Non Operating Income stood at -$17.1 million in 2021, then dropped by 11.5% to -$19.1 million in 2022, then skyrocketed by 96.42% to -$682000.0 in 2023, then surged by 48.24% to -$353000.0 in 2024, then crashed by 2734.28% to -$10.0 million in 2025.
  • Business Quant data shows Non Operating Income for PBH at -$10.0 million in Q4 2025, -$10.5 million in Q3 2025, and $224000.0 in Q2 2025.